225Ac anti N4
N/A
Report date: 2025/10/28 16:07:04
Base Information
Drug Name225Ac anti N4
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Saskatchewan
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of Saskatchewan
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A